Alloxan-induced diabetes causes morphological and ultrastructural changes in rat liver that resemble the natural history of chronic fatty liver disease in humans.
about
Mechanisms of Diabetes-Induced Liver Damage: The role of oxidative stress and inflammationMetforminium Decavanadate as a Potential Metallopharmaceutical Drug for the Treatment of Diabetes Mellitus.Oxidative Stress and First-Line Antituberculosis Drug-Induced Hepatotoxicity.Physical training reverses changes in hepatic mitochondrial diameter of Alloxan-induced diabetic rats
P2860
Alloxan-induced diabetes causes morphological and ultrastructural changes in rat liver that resemble the natural history of chronic fatty liver disease in humans.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Alloxan-induced diabetes cause ...... fatty liver disease in humans.
@en
Alloxan-induced diabetes cause ...... fatty liver disease in humans.
@nl
type
label
Alloxan-induced diabetes cause ...... fatty liver disease in humans.
@en
Alloxan-induced diabetes cause ...... fatty liver disease in humans.
@nl
prefLabel
Alloxan-induced diabetes cause ...... fatty liver disease in humans.
@en
Alloxan-induced diabetes cause ...... fatty liver disease in humans.
@nl
P2860
P356
P1476
Alloxan-induced diabetes cause ...... fatty liver disease in humans
@en
P2093
César Tadeu Spadella
Lucas Langoni Cassettari
P2860
P304
P356
10.1155/2015/494578
P577
2015-02-19T00:00:00Z